2024 Virtual Grand Rounds
2024 Virtual Grand Rounds Session 11: September 18, 2024 - Overcoming Obstacles: Optimizing Efficacy and Promoting Success in Dermatology Prior Authorizations
About
Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:
Wednesday, September 18, 2024
8 PM ET / 5 PM PT
Overcoming Obstacles: Optimizing Efficacy and Promoting Success in Dermatology Prior Authorizations
This activity is supported by educational grants from Arcutis Biotherapeutics, Inc., Lilly USA, LLC., Sanofi and Regeneron Pharmaceuticals, Inc., and Sun Pharmaceutical Industries Ltd.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
September 19, 2024
September 19, 2025
Learning Objectives
At the completion of this activity, participants should be better able to:
Review key points of the dermatology prior authorization (PA) process
Define strategies to anticipate the challenges of submitting and appealing dermatology PAs
Effectively communicate with payers and patients to better align their goals
Discuss expert approaches to collaborate with dermatology office staff throughout the PA request and appeals workflow
Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Janelle Ball
Founder & CEO, BC Educators LLC
Biologic Coordinator
Brad Glick, DO, MPH
Program Director, Dermatology Residency
Larkin Community Hospital Palm Springs Campus
Hialeah, FL
Mark Kaufmann, MD
Chief Medical Officer, Advanced Dermatology and Cosmetic Surgery
Clinical Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Ownership interest: Top MD stock
Consultant: Apogee Therapeutics, Avita Medical, Biofrontera, Dermagnostix, Dermtech,Incyte, Novan, Novartis, Rise Healthcare, Rivera Consulting, UCB, Verrica
Ownership Interest (privately held): Modernizing Medicine, Molesafe
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.